Skip to Content

Sklice FDA Approval History

FDA Approved: Yes (First approved February 7, 2012)
Brand name: Sklice
Generic name: ivermectin
Dosage form: Lotion
Company: Arbor Pharmaceuticals, LLC
Treatment for: Lice

Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and older.

Development Timeline for Sklice

DateArticle
Oct 27, 2020Approval FDA Approves Sklice (ivermectin) Lotion for Nonprescription Use to Treat Head Lice
Feb  7, 2012Approval Sanofi Announces FDA Approval of Sklice Lotion for the Treatment of Head Lice
Jun 15, 2011Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.